| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.88B | +7.7% |
| Cost of Revenue | $13.33B | +3.4% |
| Gross Profit | $24.55B | +10.2% |
| R&D Expense | $759.0M | +7.1% |
| Operating Income | $13.40B | +16.0% |
| Pre-tax Income | $12.20B | +16.7% |
| Income Tax | $3.02B | +29.0% |
| Net Income | $7.06B | -9.7% |
| EPS (Basic) | $4.53 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.22B | +37.8% |
| Accounts Receivable | $3.79B | +9.5% |
| Inventory | $9.45B | -12.3% |
| Current Assets | $20.17B | +2.1% |
| Total Assets | $61.78B | -5.4% |
| Current Liabilities | $22.91B | -13.1% |
| Long-term Debt | $42.17B | +2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.22B | +32.7% |
| Capital Expenditures | $1.44B | +9.3% |
| Investing Cash Flow | -$1.09B | +69.6% |
| Financing Cash Flow | -$9.48B | -69.8% |
| Free Cash Flow | $10.77B | +36.7% |
| -9.8% |
| EPS (Diluted) | $4.52 | -10.0% |
| Total Liabilities |
| $71.65B |
| -4.1% |
| Stockholders' Equity | -$11.75B | -4.7% |